Solid Biosciences LLC (SLDB)
Healthcare
Biotechnology
8.00 $
-0.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Solid Biosciences LLC (SLDB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -156 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.2 | -20 | -43 | -70 | -93 | -57 | -78 | -98 | -94 | -100 | -156 | |
| 0.1 | 0.1 | 0.4 | 1.6 | 2.8 | 3.9 | 3.0 | 2.4 | 2.6 | 2.5 | -1.9 | |
| 0.8 | 1.5 | 5.3 | 6.0 | 14 | 12 | 13 | 7.5 | 7.6 | 11 | 17 | |
| 0.6 | -1.4 | 4.0 | 6.0 | 14 | 12 | 13 | 7.5 | – | – | – | |
| 1.6 | 2.8 | 4.4 | -2.8 | 7.8 | 16 | -23 | -3.7 | -6.3 | 2.9 | -6.8 | |
| 0.4 | 0.4 | 2.3 | 7.8 | 4.4 | 0.9 | 1.3 | 3.0 | 1.5 | 0.7 | 1.2 | |
| -27 | -4.2 | 11 | -27 | 25 | 6.6 | -91 | 59 | 9.7 | -16 | -58 | |
| 6.8 | 3.4 | 80 | 132 | 58 | 19 | 135 | 73 | 0.0 | -5.1 | -1.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 2.1 | 0.0 | -0.5 | -0.7 | |
| 52 | 3.4 | 77 | 132 | 58 | 129 | 135 | 75 | 3.1 | 122 | 194 | |
| 21 | -21 | 44 | 35 | -10 | 79 | -34 | 36 | -81 | 6.3 | -20 | |
| -4.2 | -21 | -46 | -78 | -97 | -57 | -79 | -101 | -96 | -101 | -157 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.